Wachtell Guides Pfizer's $5.2B Anacor Deal
Pfizer, led by Wachtell Lipton Rosen & Katz, unveiled a $5.2 billion cash deal for dermatological treatment developer Anacor on Monday, marking the U.S. pharmaceutical giant's first major deal since scrapping...To view the full article, register now.
Already a subscriber? Click here to view full article